We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$2.75B
AUM Growth
-$185M
Cap. Flow
-$263M
Cap. Flow %
-9.58%
Top 10 Hldgs %
9.55%
Holding
464
New
54
Increased
146
Reduced
168
Closed
59

Sector Composition

Rank Sector Weight
1 Financials 17.72%
2 Technology 15.85%
3 Industrials 14.32%
4 Consumer Discretionary 8.43%
5 Healthcare 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HES
226
DELISTED
Hess
HES
$3.13M 0.11%
65,000
+5,000
+8% +$265K
ADTN icon
227
Adtran
ADTN
$625M
$3.13M 0.11%
150,727
+15,000
+11% +$326K
TSE
228
DELISTED
Trinseo
TSE
$3.12M 0.11%
+46,564
New +$3.13M
NCI
229
DELISTED
Navigant Consulting, Inc.
NCI
$3.1M 0.11%
135,465
-21,000
-13% -$501K
DCOM
230
DELISTED
Dime Community Bancshares
DCOM
$3.09M 0.11%
152,408
-14,000
-8% -$291K
PFPT
231
DELISTED
Proofpoint, Inc.
PFPT
$3.07M 0.11%
41,295
-35,735
-46% -$2.84M
BDC icon
232
Belden
BDC
$5.07B
$3.04M 0.11%
43,928
-43,915
-50% -$3.23M
MYGN icon
233
Myriad Genetics
MYGN
$295M
$2.93M 0.11%
152,715
+33,000
+28% +$585K
ACCO icon
234
Acco Brands
ACCO
$410M
$2.92M 0.11%
222,110
-71,522
-24% -$930K
MDC
235
DELISTED
M.D.C. Holdings, Inc.
MDC
$2.92M 0.11%
+122,192
New +$2.75M
STMP
236
DELISTED
Stamps.com, Inc.
STMP
$2.86M 0.1%
+24,195
New +$2.99M
NBIX icon
237
Neurocrine Biosciences
NBIX
$16.4B
$2.85M 0.1%
65,904
-80,108
-55% -$3.43M
EPD icon
238
Enterprise Products Partners
EPD
$82B
$2.76M 0.1%
100,000
NXTM
239
DELISTED
NxStage Medical Inc.
NXTM
$2.71M 0.1%
101,150
-47,745
-32% -$1.32M
TSRO
240
DELISTED
TESARO, Inc.
TSRO
$2.71M 0.1%
17,606
-8,356
-32% -$1.36M
LOW icon
241
Lowe's Companies
LOW
$122B
$2.7M 0.1%
32,825
-125
-0.4% -$9.57K
CRS icon
242
Carpenter Technology
CRS
$28.3B
$2.69M 0.1%
+72,000
New +$2.81M
WMGI
243
DELISTED
Wright Medical Group Inc
WMGI
$2.69M 0.1%
86,295
+17,360
+25% +$471K
LFCR icon
244
Lifecore Biomedical
LFCR
$183M
$2.68M 0.1%
223,200
-44,734
-17% -$566K
SBGI icon
245
Sinclair Inc
SBGI
$1.13B
$2.66M 0.1%
+65,675
New +$2.42M
ACIA
246
DELISTED
Acacia Communications Inc
ACIA
$2.66M 0.1%
+45,350
New +$2.63M
MKC icon
247
McCormick & Company Non-Voting
MKC
$13.9B
$2.65M 0.1%
54,410
+7,110
+15% +$344K
YELP icon
248
Yelp
YELP
$1.38B
$2.64M 0.1%
80,520
-46,341
-37% -$1.72M
CSFL
249
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$2.63M 0.1%
+101,450
New +$2.55M
RNG icon
250
RingCentral
RNG
$5.15B
$2.62M 0.1%
+92,695
New +$2.29M

Similar funds

Chartwell Investment Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Chartwell Investment Partners held 464 positions worth $2.75B, down 6.3% from $2.93B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Chartwell Investment Partners withdrew a net $263M in Q1 2017, closing 59 positions and reducing 168 holdings. Its most notable exit was Clarcor, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

Against the trend, Chartwell Investment Partners opened a new position in Integrated Device Technology I worth $20.8M.

  • Chartwell Investment Partners's largest Q1 2017 buy was Integrated Device Technology I: 879,370 shares worth $20.8M.
  • Chartwell Investment Partners added most to The Mosaic Company in Q1 2017, an estimated $7.85M increase.
  • Chartwell Investment Partners's biggest Q1 2017 reduction was Assured Guaranty, cutting an estimated $20.5M.
  • Chartwell Investment Partners fully exited Clarcor in Q1 2017, selling an estimated $22.8M.
  • Chartwell Investment Partners's ten largest holdings make up 9.6% of its $2.75B portfolio in Q1 2017.
  • Chartwell Investment Partners opened 54 new positions and closed 59 in Q1 2017.
  • Chartwell Investment Partners's portfolio value fell 6.3% quarter-over-quarter to $2.75B.

Based on Chartwell Investment Partners's 13F filing for Q1 2017, filed 12 May 2017.